Global Naloxone Spray Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
The Global Naloxone Spray Market Report by The Business Research Company covers naloxone spray market drivers and restraints, naloxone spray market size, major players, and the impact of COVID-19 on the naloxone spray market.
The naloxone spray market consists of sales of naloxone spray by entities (organizations, sole traders, and partnerships) – the product is prefilled with naloxone, and a needle-free device is sprayed into one nostril, and it requires no assembly. It is used for treating opioid emergencies with symptoms such as problems with breathing and severe sleepiness or inability to respond. Naloxone is a non-scheduled prescription drug which belongs to the class of medications called opiate antagonists, and is used to reverse or prevent the effects of opioid narcotic overdose for drugs such as codeine, fentanyl, morphine, and oxycodone. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once.
The global naloxone spray market is expected to grow from $285.09 million in 2020 to $351.39 million in 2021 at a compound annual growth rate (CAGR) of 23.3%. The change in growth trend of the naloxone spray market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The naloxone spray market is expected to reach $785.35 million in 2025 at a CAGR of 22.3%.
The increasing prevalence of opioid overdoses is contributing to the growth of the naloxone spray market. Opioids include medicines such as morphine, fentanyl, and tramadol that are used for the treatment of pain. However, due to their pharmacological effects, their non-medical use, prolonged use, misuse, and use without medical supervision can lead to opioid dependence and can cause breathing difficulties, or even lead to death or other health problems. Therefore, the increasing prevalence of opioid overdoses drives the growth of the naloxone spray market.
Request A Sample For The Global Naloxone Spray Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp
Some naloxone spray market trends include an increase in product approvals. Major companies manufacturing naloxone sprays are focused on new product approvals to broaden their product portfolios and expand their naloxone spray business.
Global naloxone spray market segments include:
1) By Dosage: 2 mg/Actuation, 4 mg/Actuation
2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others
3) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Naloxone Spray Global Market Report 2021: COVID-19 Implications And Growth At:
https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report
The Naloxone Spray Global Market Report 2021: COVID-19 Implications And Growth is one of a series of new reports from The Business Research Company that provides naloxone spray market overviews, analyzes and forecasts market size, share, naloxone spray market players, naloxone spray market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The naloxone spray identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Naloxone Spray Global Market Report 2021: COVID-19 Implications And Growth from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Naloxone Spray Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Naloxone Spray Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at www.thebusinessresearchcompany.com
Here is a list of reports from The Business Research Company similar to the Naloxone Spray Global Market Report 2021:
Central Nervous System Drugs Market 2021
